Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FAWJJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,921
Award facts
- Contract value 100% obligated
- $17,920.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,920.93 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Kesimpta 20 mg/0.4 ml pen injections. This contract is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed in Conshohocken, Pennsylvania. The award carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the prime contractor without competition for this delivery.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The parent IDC enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. Kesimpta, used in the treatment of relapsing multiple sclerosis, represents one of the specialized pharmaceutical products available through this broader contracting vehicle. The contract reflects DMS Pharmaceutical Group's established role as a key supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to deliver prescription medications and medical consumables to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FAWJJ?
SPE2DB25FAWJJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FAWJJ worth?
The government has obligated $17,921 on SPE2DB25FAWJJ.
Is contract SPE2DB25FAWJJ an order under another contract?
Yes. SPE2DB25FAWJJ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWJJ competed?
The extent of competition for SPE2DB25FAWJJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award